Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
J??lia Vergara-Alert
Affiliation
Campus de la Universitat Autonoma de Barcelona (UAB)
ORCID
Career Start Year
2011
Papers
63
H Index
21
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37981029
Middle East respiratory coronavirus (MERS-CoV) internalized by llama alveolar macrophages does not result in virus replication or induction of pro-inflammatory cytokines.
Microbes Infect
2024
36823022
Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain.
Emerg Infect Dis
2023
37717710
Quantification of camelid cytokine mRNA expression in PBMCs by microfluidic qPCR technology.
Dev Comp Immunol
2023
37793299
Transmission of severe acute respiratory syndrome coronavirus 2 from humans to animals: is there a risk of novel reservoirs?
Curr Opin Virol
2023
37620562
Animal models to study the neurological manifestations of the post-COVID-19 condition.
Lab Anim (NY)
2023
37388723
Enhanced antiviral immunity and dampened inflammation in llama lymph nodes upon MERS-CoV sensing: bridging innate and adaptive cellular immune responses in camelid reservoirs.
Front Immunol
2023
36748086
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.
iScience
2023
35231500
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis.
Antiviral Res
2022
35739576
Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas.
One Health Outlook
2022
35534728
An anti-SARS-CoV-2 metabolite is reduced in diabetes.
Nat Metab
2022
35602059
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
Front Microbiol
2022
35821254
Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Cell Mol Immunol
2022
36458182
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals.
Front Microbiol
2022
36146808
Susceptibility of Domestic Goat (<i>Capra aegagrus hircus</i>) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant.
Viruses
2022
36366408
Heterologous Systemic Prime-Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters.
Vaccines (Basel)
2022
36167932
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain.
Transbound Emerg Dis
2022
36056449
Evaluation of alpaca tracheal explants as an ex vivo model for the study of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Vet Res
2022
36320330
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.
iScience
2022
34955064
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.
Vet Pathol
2022
35012962
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Life Sci Alliance
2022
34918620
Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains in the Arabian Peninsula.
Emerg Microbes Infect
2022
35001773
Middle East respiratory syndrome coronavirus infection in camelids.
Vet Pathol
2022
34904659
Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
J Infect Dis
2022
35233547
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Cell Rep Med
2022
34082060
Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination.
J Hosp Infect
2021
33825619
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Emerg Microbes Infect
2021
33510275
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Sci Rep
2021
33554155
Stable neutralizing antibody levels 6Â months after mild and severe COVID-19 episodes.
Med
2021
34960795
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
Viruses
2021
34464958
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Nature
2021
34782760
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Cell Mol Immunol
2021
34578266
Monitoring Natural SARS-CoV-2 Infection in Lions (<i>Panthera leo</i>) at the Barcelona Zoo: Viral Dynamics and Host Responses.
Viruses
2021
34029358
Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection.
PLoS Pathog
2021
34337095
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Open Forum Infect Dis
2021
32948692
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
Proc Natl Acad Sci U S A
2020
32900263
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins.
Immunotherapy
2020
30520548
Co-localization of Middle East respiratory syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract and lymphoid tissues of pigs and llamas.
Transbound Emerg Dis
2019
31711379
Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
Emerg Microbes Infect
2019
31553755
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
PLoS One
2019
30822308
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
PLoS One
2019
29249314
Protective effect of a polyvalent influenza DNA vaccine in pigs.
Vet Immunol Immunopathol
2018
29950581
Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4.
Sci Rep
2018
29536643
Emergence and spread of highly pathogenic avian influenza A(H5N8) in Europe in 2016-2017.
Transbound Emerg Dis
2018
27901465
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus.
Emerg Infect Dis
2017
28432192
Evidence that avian influenza vaccination induces long-lived immune responses in zoo birds.
Vet Rec
2017
29141036
The disjunct pattern of the Neotropical harvestman Discocyrtus dilatatus (Gonyleptidae) explained by climate-driven range shifts in the Quaternary: Paleodistributional and molecular evidence.
PLoS One
2017
28616501
Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus.
One Health
2017
28653496
Middle East respiratory syndrome coronavirus experimental transmission using a pig model.
Transbound Emerg Dis
2017
27151883
Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.).
Vaccine
2016
26475282
Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.
Med Microbiol Immunol
2016
1 - 50 of 63
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
6
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year
2015
Number of shared co-authors
10
Ying Shi
Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Career Start Year
2014
Number of shared co-authors
7
Chester McDowell
College of Veterinary Medicine, Kansas State University
Career Start Year
2013
Number of shared co-authors
5
Meagan E Deming
University of Maryland School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Ana S Gonzalez-Reiche
Icahn School of Medicine at Mount Sinai
Career Start Year
2010
Number of shared co-authors
5
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2010
Number of shared co-authors
5
Velmurugan Balaraman
College of Veterinary Medicine, Kansas State University
Career Start Year
2009
Number of shared co-authors
5
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
0
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
3
Qiyun Zhu
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year
2007
Number of shared co-authors
0
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Career Start Year
2007
Number of shared co-authors
1
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
1
Guojun Wang
College of Life Sciences, Inner Mongolia University
Career Start Year
2005
Number of shared co-authors
4
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
6
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year
2003
Number of shared co-authors
2
Wan-Mui Chan
School of Clinical Medicine, The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
0
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
7
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
11
Man-Seong Park
Korea University College of Medicine
Career Start Year
2001
Number of shared co-authors
1
Rong Hai
University of California riverside
Career Start Year
1999
Number of shared co-authors
2
Gary P Kobinger
University of Texas Medical Branch
Career Start Year
1997
Number of shared co-authors
2
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year
1994
Number of shared co-authors
11
Laurent Kaiser
Geneva University Hospital
Career Start Year
1993
Number of shared co-authors
3
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
1
Terrence M Tumpey
Centers for Disease Control and Prevention.
Career Start Year
1989
Number of shared co-authors
2
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Career Start Year
1988
Number of shared co-authors
6
Marion Koopmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
6
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
3
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year
1979
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers
27
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers
19
Nuria Izquierdo-Useros
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers
19
Benjamin Trinité
Co-authored papers
11
Roger Paredes
Hospital Germans Trias i Pujol
Co-authored papers
8
Bart L Haagmans
Erasmus Medical Center
Co-authored papers
8
Veljko Veljkovic
Institute of Nuclear Sciences VINCA
Co-authored papers
3
Alfonso Valencia
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers
3
Stephan Becker
Institute of Virology, Philipps University Marburg
Co-authored papers
3
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers
3
Luis Enjuanes
Campus Universidad Autonoma de Madrid
Co-authored papers
2
Isabel Sola
Campus Universidad Autonoma de Madrid
Co-authored papers
2
Miguel Romero-Durana
Pontificia Universidad Javeriana
Co-authored papers
2
Pablo Avil??s
Departamento de Toxicologia y Farmacologia Preclinica
Co-authored papers
2
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Co-authored papers
2
Javier G??mez
Hospital Universitario Marques de Valdecilla
Co-authored papers
1
Lucy Thorne
University College London
Co-authored papers
1
Daniel Abad
Universidad Europea
Co-authored papers
1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Pedro Landete
Hospital Universitario de La Princesa
Co-authored papers
1
Maria J S L Pontes
Co-authored papers
1
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers
1
Alejandro Losada
Hospital Infantil Universitario "La Paz"
Co-authored papers
1
Jes??s Fort??n
Hospital Universitario Ramon y Cajal
Co-authored papers
1
Alfonso Monereo
Hospital Universitario de Getafe
Co-authored papers
1
Alvaro Belgrano
Co-authored papers
1
Daniel Carnevali-Ruiz
Hospital Universitario Quironsalud Madrid
Co-authored papers
1
Soner Yildiz
University of Geneva
Co-authored papers
1
Julio Ancochea
Instituto de Salud Carlos III, Hospital Universitario La Princesa
Co-authored papers
1
Sonia Zu??iga
Campus Universidad Autonoma de Madrid
Co-authored papers
1
1 - 30